Fidelity Investments’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Fidelity Investments’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,000	Closed	-$3K	–	5738
2021 Q4	$3K	Buy	+2,000	New	+$4.73K	﹤0.01%	3974
2021 Q2	–	Sell	-800	Closed	-$3K	–	5154
2021 Q1	$3K	Buy	+800	New	+$15.1K	﹤0.01%	3685
2020 Q3	–	Sell	-70,416	Closed	-$2.98M	–	4133
2020 Q2	$2.98M	Sell	70,416 -84,200	-54%	-$2.72M	﹤0.01%	2189
2020 Q1	$4.27M	Hold	154,616	–	–	﹤0.01%	1986
2019 Q4	$5.02M	Sell	154,616 -109,900	-42%	-$3.41M	﹤0.01%	2047
2019 Q3	$6.89M	Sell	264,516 -134,110	-34%	-$4.49M	﹤0.01%	1952
2019 Q2	$14.6M	Sell	398,626 -19,668	-5%	-$471K	﹤0.01%	1747
2019 Q1	$9.25M	Sell	418,294 -8,000	-2%	-$140K	﹤0.01%	1887
2018 Q4	$6M	Sell	426,294 -78,600	-16%	-$1.22M	﹤0.01%	1973
2018 Q3	$9.8M	Sell	504,894 -345,106	-41%	-$7.04M	﹤0.01%	1942
2018 Q2	$18.8M	Hold	850,000	–	–	﹤0.01%	1744
2018 Q1	$18M	Hold	850,000	–	–	﹤0.01%	1766
2017 Q4	$21.3M	Buy	+850,000	New	+$20.1M	﹤0.01%	1696

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Fidelity Investments's ODT Position: Q1 2022 in Review

Fidelity Investments sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 2,000 shares — an estimated $3K sold.

Fidelity Investments first reported a position in ODT in Q4 2017 and held it in 13 quarters. The position peaked at $21.3M in Q4 2017. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

Fidelity Investments reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Fidelity Investments sold 2,000 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $3K.
Fidelity Investments first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2017 and held it in 13 quarters.
Fidelity Investments's Odonate Therapeutics, Inc. Common Stock position peaked at $21.3M in Q4 2017.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.